ANEB
Anebulo Pharmaceuticals Inc
NASDAQ: ANEB · HEALTHCARE · BIOTECHNOLOGY
$0.43
-11.78% today
Updated 2026-04-29
Market cap
$22.43M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.18
Dividend yield
—
52W range
$0 – $3
Volume
0.0M
Anebulo Pharmaceuticals Inc (ANEB) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-0.70%
ROA
-0.45%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2020 | — | $-174637.00 | — | — | — |
| 2021 | $0.00 | $-30.25M | — | — | — |
| 2022 | $0.00 | $-6.83M | — | — | — |
| 2023 | $0.00 | $-11.73M | — | — | — |
| 2024 | $0.00 | $-8.20M | — | — | — |
| 2025 | $0.00 | $-8.48M | — | — | — |